# What Lab Tests Might a Clinician Discuss Before GLP-1 Treatment?

Which blood tests a clinician may raise before semaglutide or tirzepatide, what the labeling actually requires, why no universal panel exists, and how to ask who pays for them.

Canonical HTML: [What Lab Tests Might a Clinician Discuss Before GLP-1 Treatment?](https://joinelovi.com/blog/what-lab-tests-might-a-clinician-discuss-before-glp-1-treatment)

Prepared by [Ēlovi Editorial](https://joinelovi.com/blog/authors/elovi-editorial).
Published: 2026-10-02T02:39:00.000Z. Updated: 2026-10-02T02:39:00.000Z.
Prepared by Ēlovi Editorial with AI assistance. Sources checked: 2026-10-02. Reviewed by the Ēlovi editorial team, which includes licensed clinicians.
[Editorial process](https://joinelovi.com/blog/editorial-policy).

## The short answer

No single lab panel is required before every GLP-1 prescription. The Wegovy and Zepbound prescribing information calls for blood glucose monitoring in people who have diabetes and for kidney function checks in anyone who develops vomiting or diarrhea that could cause dehydration, and it says routine calcitonin or thyroid ultrasound screening is of uncertain value. Whether your clinician orders an A1C, kidney, liver, lipid, or other test depends on your history, your medications, and what a recent result already shows. Ask which tests are being ordered, why, and who bills for them.

## When does a lab question need care now, not a lab appointment?

Labs are for planning. They are not a place to park a symptom. Get emergency care for swelling of the face, mouth, tongue, or throat, trouble breathing, or fainting. [3](https://medlineplus.gov/druginfo/meds/a618008.html) Contact your prescriber promptly, or seek emergency care, for severe or persistent abdominal pain that may spread to your back, a lump or swelling in your neck, hoarseness or trouble swallowing, vomiting or diarrhea you cannot keep up with, or very little urination. [3](https://medlineplus.gov/druginfo/meds/a618008.html) The labeling links acute kidney injury to dehydration from nausea, vomiting, or diarrhea, which is why it asks for kidney function to be monitored in that situation. [1](https://www.novo-pi.com/wegovy.pdf) [2](https://pi.lilly.com/us/zepbound-uspi.pdf) None of these should wait for a scheduled blood draw.

## Is there one standard lab panel before GLP-1 treatment?

No. The labeling does not list a universal pre-treatment panel. What it does list is monitoring tied to particular situations. [1](https://www.novo-pi.com/wegovy.pdf) [2](https://pi.lilly.com/us/zepbound-uspi.pdf)

- **Diabetes:** both labels say to monitor blood glucose before starting and during treatment in people with diabetes. [1](https://www.novo-pi.com/wegovy.pdf) [2](https://pi.lilly.com/us/zepbound-uspi.pdf)
- **Dehydration risk:** both labels say to monitor kidney function in patients who report adverse reactions that could lead to volume depletion, especially while treatment is starting and being adjusted. [1](https://www.novo-pi.com/wegovy.pdf) [2](https://pi.lilly.com/us/zepbound-uspi.pdf)
- **Diabetic retinopathy:** both labels say people with a history of it should be monitored for progression. That is an eye exam, not a blood test. [1](https://www.novo-pi.com/wegovy.pdf) [2](https://pi.lilly.com/us/zepbound-uspi.pdf)
- **Thyroid:** both labels say routine calcitonin measurement or thyroid ultrasound is of uncertain value for early detection of medullary thyroid cancer, and may lead to unnecessary procedures. If a calcitonin level is measured and is significantly elevated, or a thyroid nodule is found, further evaluation is advised. [1](https://www.novo-pi.com/wegovy.pdf) [2](https://pi.lilly.com/us/zepbound-uspi.pdf)

MedlinePlus adds that your doctor may order certain tests to check your body's response, and asks you to keep your laboratory appointments. [3](https://medlineplus.gov/druginfo/meds/a618008.html) That is a general statement, not a list. What your clinician orders is a clinical decision about you.

## Which tests might come up, and why?

The table below is a planning aid we wrote, not a required list. "What it can tell your clinician" is general; whether any row applies to you is for your clinician to say.

| Test or check | What it can tell your clinician | Where it comes from |
| --- | --- | --- |
| **A1C or fasting glucose** | Average blood glucose over about 3 months (A1C), which helps identify prediabetes or diabetes. A normal A1C is below 5.7 percent. [4](https://www.niddk.nih.gov/health-information/diagnostic-tests/a1c-test) | Labeling calls for glucose monitoring if you have diabetes. [1](https://www.novo-pi.com/wegovy.pdf) [2](https://pi.lilly.com/us/zepbound-uspi.pdf) |
| **Kidney function (creatinine, eGFR)** | A baseline to compare against if dehydration happens later | Labeling calls for monitoring when vomiting, diarrhea, or poor intake could cause volume depletion. [1](https://www.novo-pi.com/wegovy.pdf) [2](https://pi.lilly.com/us/zepbound-uspi.pdf) |
| **Lipids and blood pressure** | Heart-disease risk factors that often sit alongside excess weight [5](https://www.niddk.nih.gov/health-information/weight-management/adult-overweight-obesity/health-risks) | Weight-related conditions are part of how a clinician frames the conversation. [5](https://www.niddk.nih.gov/health-information/weight-management/adult-overweight-obesity/health-risks) |
| **Liver tests** | Relevant background if you have liver disease or take other medicines the liver processes | Clinician judgment; not a labeling requirement for weight care in general |
| **Pregnancy test** | Both labels say treatment may cause fetal harm, and MedlinePlus says to stop semaglutide injection 2 months before a planned pregnancy. [1](https://www.novo-pi.com/wegovy.pdf) [2](https://pi.lilly.com/us/zepbound-uspi.pdf) [3](https://medlineplus.gov/druginfo/meds/a618008.html) | Raised through your history; tell your clinician if you could be or plan to be pregnant |
| **Calcitonin, thyroid ultrasound** | Not a routine screen, per labeling [1](https://www.novo-pi.com/wegovy.pdf) [2](https://pi.lilly.com/us/zepbound-uspi.pdf) | Considered if there is a nodule, symptoms, or a relevant history |

The thyroid row matters most to read carefully. Both labels list two separate contraindications: a personal or family history of medullary thyroid carcinoma, and a diagnosis of MEN 2 in the patient. [1](https://www.novo-pi.com/wegovy.pdf) [2](https://pi.lilly.com/us/zepbound-uspi.pdf) A relative's MEN 2 is a reason to tell your clinician, who decides what it means for you. History is gathered by asking you, not by a lab test, so give a complete answer about your family.

## Why might your clinician skip a test, or order extra ones?

Three things change the list.

1. **You already have a recent result.** A recent A1C or kidney panel from your primary care visit may do the job. Ask whether your clinician can use it.
2. **Your history points somewhere specific.** Diabetes, kidney disease, liver disease, pancreatitis, or gallbladder disease each change what is worth checking and how closely. MedlinePlus lists pancreatitis, gallbladder disease, kidney disease, and problems digesting food among the things to tell your doctor about before starting. [3](https://medlineplus.gov/druginfo/meds/a618008.html)
3. **Other medicines are in play.** Keep a current list. Our [medication-list checklist](https://joinelovi.com/blog/who-can-take-glp-1) covers what to bring.

No test result on its own decides whether you can take a GLP-1. A clinician weighs results with your history, medications, and goals. The evidence on which routine tests improve outcomes is not settled for every case, so a clinician who orders fewer tests is not necessarily doing less.

## How do I ask about lab tests, and who pays?

Use this short script before a lab order is placed. It works the same way at an in-person practice or an online program.

| Ask | Why it matters |
| --- | --- |
| Which tests are you ordering, and what would each result change? | Separates tests that guide treatment from tests that are routine habit |
| Can you use results I already have from the last few months? | May avoid a repeat draw and a repeat bill |
| Are any of these needed before a prescription, or only during follow-up? | Timing affects when treatment can start |
| Who orders the draw, which lab runs it, and who bills me? | An outside laboratory may send its own bill |
| Will insurance cover the lab if I submit it? | Coverage for diagnostic labs is separate from coverage for the medicine; our [insurer question list](https://joinelovi.com/blog/questions-to-ask-your-insurer-about-glp-1-coverage) helps |
| What would make you order more tests later? | Sets expectations for dehydration, new symptoms, or a dose change |

On cost: Ēlovi's published plan lists outside laboratory testing as excluded from the plan price, so a lab you take elsewhere may be billed separately. Our [cost guide](https://joinelovi.com/blog/glp-1-cost) walks through the other categories worth budgeting for. For what an online visit covers and what you are asked to share, see [what happens at an online GLP-1 appointment](https://joinelovi.com/blog/what-happens-at-an-online-glp-1-appointment).

## Common questions

### Do I need blood work before I can start semaglutide or tirzepatide?

Not by labeling alone. The labels call for glucose monitoring in people with diabetes and kidney monitoring in specific situations. [1](https://www.novo-pi.com/wegovy.pdf) [2](https://pi.lilly.com/us/zepbound-uspi.pdf) Whether your clinician wants baseline results first is their judgment. Ask them, rather than assuming a test is or is not needed.

### Should I ask for a thyroid test because of the thyroid warning?

The labeling says routine calcitonin testing and thyroid ultrasound are of uncertain value for screening and may lead to unnecessary procedures. [1](https://www.novo-pi.com/wegovy.pdf) [2](https://pi.lilly.com/us/zepbound-uspi.pdf) What the warning asks of you is an accurate personal and family history. If you have a neck lump, hoarseness, or trouble swallowing, tell your clinician. [3](https://medlineplus.gov/druginfo/meds/a618008.html)

### Can a lab result tell me I am eligible?

No. Results feed a clinician's assessment. They do not make you eligible or ineligible on their own. For the broader picture, see [who can take a GLP-1 for weight loss](https://joinelovi.com/blog/who-can-take-glp-1).

### Do labs continue after I start?

Possibly. MedlinePlus says to keep your laboratory appointments because your doctor may order tests to check your response. [3](https://medlineplus.gov/druginfo/meds/a618008.html) Which tests, and how often, is set by your prescriber.

## References

1. [Wegovy Prescribing Information](https://www.novo-pi.com/wegovy.pdf) — Novo Nordisk
2. [Zepbound Prescribing Information](https://pi.lilly.com/us/zepbound-uspi.pdf) — Eli Lilly
3. [Semaglutide Injection](https://medlineplus.gov/druginfo/meds/a618008.html) — MedlinePlus, U.S. National Library of Medicine
4. [The A1C Test & Diabetes](https://www.niddk.nih.gov/health-information/diagnostic-tests/a1c-test) — National Institute of Diabetes and Digestive and Kidney Diseases
5. [Health Risks of Overweight & Obesity](https://www.niddk.nih.gov/health-information/weight-management/adult-overweight-obesity/health-risks) — National Institute of Diabetes and Digestive and Kidney Diseases

For general education; this does not replace medical advice or an individual evaluation. Talk to your clinician before starting, changing, or stopping treatment. Compounded medications are not FDA-approved.